French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3.
Identifieur interne : 001594 ( Main/Exploration ); précédent : 001593; suivant : 001595French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3.
Auteurs : F. Joly [France] ; M. Lange ; O. Rigal ; H. Correia ; B. Giffard ; J L Beaumont ; S. Clisant ; L. WagnerSource :
- Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [ 1433-7339 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Antinéoplasiques (effets indésirables), Autorapport (MeSH), Cognition (MeSH), Enquêtes et questionnaires (MeSH), Femelle (MeSH), Humains (MeSH), Mâle (MeSH), Psychométrie (instrumentation), Qualité de vie (MeSH), Reproductibilité des résultats (MeSH), Sujet âgé (MeSH), Troubles de la cognition (diagnostic), Troubles de la cognition (psychologie), Troubles de la cognition (étiologie), Tumeurs (psychologie), Tumeurs (traitement médicamenteux).
- MESH :
- diagnostic : Troubles de la cognition.
- effets indésirables : Antinéoplasiques.
- psychologie : Troubles de la cognition, Tumeurs.
- traitement médicamenteux : Psychométrie, Tumeurs.
- étiologie : Troubles de la cognition.
- Adulte, Adulte d'âge moyen, Autorapport, Cognition, Enquêtes et questionnaires, Femelle, Humains, Mâle, Qualité de vie, Reproductibilité des résultats, Sujet âgé.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Antineoplastic Agents (adverse effects), Cognition (MeSH), Cognition Disorders (diagnosis), Cognition Disorders (etiology), Cognition Disorders (psychology), Female (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Neoplasms (drug therapy), Neoplasms (psychology), Psychometrics (instrumentation), Quality of Life (MeSH), Reproducibility of Results (MeSH), Self Report (MeSH), Surveys and Questionnaires (MeSH).
- MESH :
- chemical , adverse effects : Antineoplastic Agents.
- diagnosis : Cognition Disorders.
- drug therapy : Neoplasms.
- etiology : Cognition Disorders.
- instrumentation : Psychometrics.
- psychology : Cognition Disorders, Neoplasms.
- Adult, Aged, Cognition, Female, Humans, Male, Middle Aged, Quality of Life, Reproducibility of Results, Self Report, Surveys and Questionnaires.
Abstract
PURPOSE
Impairment of cognitive function, a common complaint in patients receiving chemotherapy, is usually measured through neuropsychological tests. Patient self-evaluation of cognitive difficulties is an important complement to those tests. The Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) is a self-report questionnaire with potential to be used in standard clinical practice as a tool for evaluating patient's cognitive function before, during, and after chemotherapy. The purpose of our study was to conduct linguistic validation of the French version of the FACT-Cog.
METHODS
Both qualitative and quantitative methods were used in this study. After undergoing a rigorous translation methodology, the French FACT-Cog version was pretested in France with 35 cancer patients undergoing chemotherapy treatment. Interviews were conducted with all patients to ascertain their understanding of each item. The validation of the final version was conducted among 63 cancer patients, and sociodemographic information was collected as well as brief measure of cognitive function and depression score.
RESULTS
Patient comments obtained through the cognitive debriefing interviews indicated that patients understand the French FACT-Cog items as they are intended and that the measure is culturally appropriate. Internal consistency reliability of the subscales, evaluated using Cronbach's coefficient alpha, was high for all four subscales: Perceived Cognitive Impairments = 0.93, Impact On QOL = 0.85, Comments From Others = 0.70, and Perceived Cognitive Abilities = 0.89. All item-total correlations for each subscale were greater than 0.20, and most were greater than 0.50.
CONCLUSIONS
Results from this study effectively demonstrate that the French FACT-Cog is a reliable instrument for the self-reporting of cognitive abilities in patients undergoing chemotherapy.
DOI: 10.1007/s00520-012-1439-2
PubMed: 22549504
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3.</title><author><name sortKey="Joly, F" sort="Joly, F" uniqKey="Joly F" first="F" last="Joly">F. Joly</name><affiliation wicri:level="3"><nlm:affiliation>Département d'oncologie médicale, Unité de Recherche Clinique, Centre François Baclesse, Caen, France. f.joly@baclesse.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département d'oncologie médicale, Unité de Recherche Clinique, Centre François Baclesse, Caen</wicri:regionArea><placeName><region type="region">Région Normandie</region><region type="old region">Basse-Normandie</region><settlement type="city">Caen</settlement></placeName></affiliation></author><author><name sortKey="Lange, M" sort="Lange, M" uniqKey="Lange M" first="M" last="Lange">M. Lange</name></author><author><name sortKey="Rigal, O" sort="Rigal, O" uniqKey="Rigal O" first="O" last="Rigal">O. Rigal</name></author><author><name sortKey="Correia, H" sort="Correia, H" uniqKey="Correia H" first="H" last="Correia">H. Correia</name></author><author><name sortKey="Giffard, B" sort="Giffard, B" uniqKey="Giffard B" first="B" last="Giffard">B. Giffard</name></author><author><name sortKey="Beaumont, J L" sort="Beaumont, J L" uniqKey="Beaumont J" first="J L" last="Beaumont">J L Beaumont</name></author><author><name sortKey="Clisant, S" sort="Clisant, S" uniqKey="Clisant S" first="S" last="Clisant">S. Clisant</name></author><author><name sortKey="Wagner, L" sort="Wagner, L" uniqKey="Wagner L" first="L" last="Wagner">L. Wagner</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22549504</idno><idno type="pmid">22549504</idno><idno type="doi">10.1007/s00520-012-1439-2</idno><idno type="wicri:Area/Main/Corpus">001567</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001567</idno><idno type="wicri:Area/Main/Curation">001567</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001567</idno><idno type="wicri:Area/Main/Exploration">001567</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3.</title><author><name sortKey="Joly, F" sort="Joly, F" uniqKey="Joly F" first="F" last="Joly">F. Joly</name><affiliation wicri:level="3"><nlm:affiliation>Département d'oncologie médicale, Unité de Recherche Clinique, Centre François Baclesse, Caen, France. f.joly@baclesse.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département d'oncologie médicale, Unité de Recherche Clinique, Centre François Baclesse, Caen</wicri:regionArea><placeName><region type="region">Région Normandie</region><region type="old region">Basse-Normandie</region><settlement type="city">Caen</settlement></placeName></affiliation></author><author><name sortKey="Lange, M" sort="Lange, M" uniqKey="Lange M" first="M" last="Lange">M. Lange</name></author><author><name sortKey="Rigal, O" sort="Rigal, O" uniqKey="Rigal O" first="O" last="Rigal">O. Rigal</name></author><author><name sortKey="Correia, H" sort="Correia, H" uniqKey="Correia H" first="H" last="Correia">H. Correia</name></author><author><name sortKey="Giffard, B" sort="Giffard, B" uniqKey="Giffard B" first="B" last="Giffard">B. Giffard</name></author><author><name sortKey="Beaumont, J L" sort="Beaumont, J L" uniqKey="Beaumont J" first="J L" last="Beaumont">J L Beaumont</name></author><author><name sortKey="Clisant, S" sort="Clisant, S" uniqKey="Clisant S" first="S" last="Clisant">S. Clisant</name></author><author><name sortKey="Wagner, L" sort="Wagner, L" uniqKey="Wagner L" first="L" last="Wagner">L. Wagner</name></author></analytic><series><title level="j">Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</title><idno type="eISSN">1433-7339</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Antineoplastic Agents (adverse effects)</term><term>Cognition (MeSH)</term><term>Cognition Disorders (diagnosis)</term><term>Cognition Disorders (etiology)</term><term>Cognition Disorders (psychology)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Neoplasms (drug therapy)</term><term>Neoplasms (psychology)</term><term>Psychometrics (instrumentation)</term><term>Quality of Life (MeSH)</term><term>Reproducibility of Results (MeSH)</term><term>Self Report (MeSH)</term><term>Surveys and Questionnaires (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Antinéoplasiques (effets indésirables)</term><term>Autorapport (MeSH)</term><term>Cognition (MeSH)</term><term>Enquêtes et questionnaires (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Mâle (MeSH)</term><term>Psychométrie (instrumentation)</term><term>Qualité de vie (MeSH)</term><term>Reproductibilité des résultats (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Troubles de la cognition (diagnostic)</term><term>Troubles de la cognition (psychologie)</term><term>Troubles de la cognition (étiologie)</term><term>Tumeurs (psychologie)</term><term>Tumeurs (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognition Disorders</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Troubles de la cognition</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cognition Disorders</term></keywords><keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Psychometrics</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Troubles de la cognition</term><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Cognition Disorders</term><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Psychométrie</term><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Troubles de la cognition</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Cognition</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Quality of Life</term><term>Reproducibility of Results</term><term>Self Report</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Autorapport</term><term>Cognition</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Qualité de vie</term><term>Reproductibilité des résultats</term><term>Sujet âgé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>PURPOSE</b></p><p>Impairment of cognitive function, a common complaint in patients receiving chemotherapy, is usually measured through neuropsychological tests. Patient self-evaluation of cognitive difficulties is an important complement to those tests. The Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) is a self-report questionnaire with potential to be used in standard clinical practice as a tool for evaluating patient's cognitive function before, during, and after chemotherapy. The purpose of our study was to conduct linguistic validation of the French version of the FACT-Cog.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Both qualitative and quantitative methods were used in this study. After undergoing a rigorous translation methodology, the French FACT-Cog version was pretested in France with 35 cancer patients undergoing chemotherapy treatment. Interviews were conducted with all patients to ascertain their understanding of each item. The validation of the final version was conducted among 63 cancer patients, and sociodemographic information was collected as well as brief measure of cognitive function and depression score.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Patient comments obtained through the cognitive debriefing interviews indicated that patients understand the French FACT-Cog items as they are intended and that the measure is culturally appropriate. Internal consistency reliability of the subscales, evaluated using Cronbach's coefficient alpha, was high for all four subscales: Perceived Cognitive Impairments = 0.93, Impact On QOL = 0.85, Comments From Others = 0.70, and Perceived Cognitive Abilities = 0.89. All item-total correlations for each subscale were greater than 0.20, and most were greater than 0.50.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Results from this study effectively demonstrate that the French FACT-Cog is a reliable instrument for the self-reporting of cognitive abilities in patients undergoing chemotherapy.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22549504</PMID><DateCompleted><Year>2013</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-7339</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>12</Issue><PubDate><Year>2012</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</Title><ISOAbbreviation>Support Care Cancer</ISOAbbreviation></Journal><ArticleTitle>French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3.</ArticleTitle><Pagination><MedlinePgn>3297-305</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00520-012-1439-2</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Impairment of cognitive function, a common complaint in patients receiving chemotherapy, is usually measured through neuropsychological tests. Patient self-evaluation of cognitive difficulties is an important complement to those tests. The Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) is a self-report questionnaire with potential to be used in standard clinical practice as a tool for evaluating patient's cognitive function before, during, and after chemotherapy. The purpose of our study was to conduct linguistic validation of the French version of the FACT-Cog.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Both qualitative and quantitative methods were used in this study. After undergoing a rigorous translation methodology, the French FACT-Cog version was pretested in France with 35 cancer patients undergoing chemotherapy treatment. Interviews were conducted with all patients to ascertain their understanding of each item. The validation of the final version was conducted among 63 cancer patients, and sociodemographic information was collected as well as brief measure of cognitive function and depression score.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patient comments obtained through the cognitive debriefing interviews indicated that patients understand the French FACT-Cog items as they are intended and that the measure is culturally appropriate. Internal consistency reliability of the subscales, evaluated using Cronbach's coefficient alpha, was high for all four subscales: Perceived Cognitive Impairments = 0.93, Impact On QOL = 0.85, Comments From Others = 0.70, and Perceived Cognitive Abilities = 0.89. All item-total correlations for each subscale were greater than 0.20, and most were greater than 0.50.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Results from this study effectively demonstrate that the French FACT-Cog is a reliable instrument for the self-reporting of cognitive abilities in patients undergoing chemotherapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joly</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Département d'oncologie médicale, Unité de Recherche Clinique, Centre François Baclesse, Caen, France. f.joly@baclesse.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rigal</LastName><ForeName>O</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Correia</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Giffard</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Beaumont</LastName><ForeName>J L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Clisant</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>L</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Support Care Cancer</MedlineTA><NlmUniqueID>9302957</NlmUniqueID><ISSNLinking>0941-4355</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Support Care Cancer. 2013 Mar;21(3):655-6</RefSource><PMID Version="1">23089944</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="Y">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>09</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22549504</ArticleId><ArticleId IdType="doi">10.1007/s00520-012-1439-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Clin Oncol. 2004 Jun 1;22(11):2233-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15169812</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychooncology. 2010 Nov;19(11):1127-38</Citation><ArticleIdList><ArticleId IdType="pubmed">20020424</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychooncology. 2011 Feb;20(2):194-202</Citation><ArticleIdList><ArticleId IdType="pubmed">20213858</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2002 Sep;13(9):1387-97</Citation><ArticleIdList><ArticleId IdType="pubmed">12196364</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 2006 Nov;14(11):1111-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16538498</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 1996 Jun;5(3):309-20</Citation><ArticleIdList><ArticleId IdType="pubmed">8763799</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 1975 Nov;12(3):189-98</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychooncology. 2011 Dec;20(12):1251-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21254307</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer Care (Engl). 2012 Jul;21(4):485-92</Citation><ArticleIdList><ArticleId IdType="pubmed">22211832</ArticleId></ArticleIdList></Reference><Reference><Citation>Eval Health Prof. 2005 Jun;28(2):212-32</Citation><ArticleIdList><ArticleId IdType="pubmed">15851774</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Clin Neuropsychol. 2006 May;21(4):327-37</Citation><ArticleIdList><ArticleId IdType="pubmed">16769198</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62</Citation><ArticleIdList><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Oncol. 1999;38(6):695-702</Citation><ArticleIdList><ArticleId IdType="pubmed">10522759</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Basse-Normandie</li><li>Région Normandie</li></region><settlement><li>Caen</li></settlement></list><tree><noCountry><name sortKey="Beaumont, J L" sort="Beaumont, J L" uniqKey="Beaumont J" first="J L" last="Beaumont">J L Beaumont</name><name sortKey="Clisant, S" sort="Clisant, S" uniqKey="Clisant S" first="S" last="Clisant">S. Clisant</name><name sortKey="Correia, H" sort="Correia, H" uniqKey="Correia H" first="H" last="Correia">H. Correia</name><name sortKey="Giffard, B" sort="Giffard, B" uniqKey="Giffard B" first="B" last="Giffard">B. Giffard</name><name sortKey="Lange, M" sort="Lange, M" uniqKey="Lange M" first="M" last="Lange">M. Lange</name><name sortKey="Rigal, O" sort="Rigal, O" uniqKey="Rigal O" first="O" last="Rigal">O. Rigal</name><name sortKey="Wagner, L" sort="Wagner, L" uniqKey="Wagner L" first="L" last="Wagner">L. Wagner</name></noCountry><country name="France"><region name="Région Normandie"><name sortKey="Joly, F" sort="Joly, F" uniqKey="Joly F" first="F" last="Joly">F. Joly</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001594 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001594 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:22549504
|texte= French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22549504" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |